104 related articles for article (PubMed ID: 10802379)
1. Preclinical evaluation of the orally active camptothecin analog, RFS-2000 (9-nitro-20(S)-camptothecin) as a radiation enhancer.
Amorino GP; Hercules SK; Mohr PJ; Pyo H; Choy H
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):503-9. PubMed ID: 10802379
[TBL] [Abstract][Full Text] [Related]
2. Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells.
Kim JS; Amorino GP; Pyo H; Cao Q; Choy H
Radiother Oncol; 2002 Jan; 62(1):61-7. PubMed ID: 11830313
[TBL] [Abstract][Full Text] [Related]
3. Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition.
Amorino GP; Freeman ML; Carbone DP; Lebwohl DE; Choy H
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):399-405. PubMed ID: 10760436
[TBL] [Abstract][Full Text] [Related]
4. The novel taxane analogs, BMS-184476 and BMS-188797, potentiate the effects of radiation therapy in vitro and in vivo against human lung cancer cells.
Kim JS; Amorino GP; Pyo H; Cao Q; Price JO; Choy H
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):525-34. PubMed ID: 11567829
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of radiation effects by combined docetaxel and flavopiridol treatment in lung cancer cells.
Kim JC; Saha D; Cao Q; Choy H
Radiother Oncol; 2004 May; 71(2):213-21. PubMed ID: 15110456
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of the orally active cisplatin analog, JM216, and radiation in antitumor therapy.
Amorino GP; Mohr PJ; Hercules SK; Pyo H; Choy H
Cancer Chemother Pharmacol; 2000; 46(5):423-6. PubMed ID: 11127948
[TBL] [Abstract][Full Text] [Related]
7. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
[TBL] [Abstract][Full Text] [Related]
8. Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.
Schütze C; Dörfler A; Eicheler W; Zips D; Hering S; Solca F; Baumann M; Krause M
Strahlenther Onkol; 2007 May; 183(5):256-64. PubMed ID: 17497097
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
Kirichenko AV; Rich TA; Newman RA; Travis EL
Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of camptothecin congeners in the treatment of human breast carcinoma xenografts.
Pantazis P; Kozielski AJ; Vardeman DM; Petry ER; Giovanella BC
Oncol Res; 1993; 5(8):273-81. PubMed ID: 8012059
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of an estrogen metabolite-induced potentiation of radiation antitumor effects in presence of wild-type p53 in non-small-cell lung cancer.
Huober JB; Nakamura S; Meyn R; Roth JA; Mukhopadhyay T
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1127-37. PubMed ID: 11072172
[TBL] [Abstract][Full Text] [Related]
12. Enhancement by N-methylformamide of the effect of ionizing radiation on a human colon tumor xenografted in nude mice.
Dexter DL; Lee ES; Bliven SF; Glicksman AS; Leith JT
Cancer Res; 1984 Nov; 44(11):4942-6. PubMed ID: 6488157
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel combined with fractionated radiation in vitro: a study with vulvar squamous cell carcinoma cell lines.
Raitanen M; Rantanen V; Kulmala J; Pulkkinen J; Klemi P; Grénman S; Grénman R
Int J Cancer; 2002 Feb; 97(6):853-7. PubMed ID: 11857367
[TBL] [Abstract][Full Text] [Related]
14. Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation.
Lamond JP; Wang M; Kinsella TJ; Boothman DA
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):361-8. PubMed ID: 8892461
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells.
Harada K; Kawaguchi S; Supriatno ; Onoue T; Yoshida H; Sato M
Oral Oncol; 2004 Aug; 40(7):713-9. PubMed ID: 15172641
[TBL] [Abstract][Full Text] [Related]
16. Potential radiation-sensitizing effect of semisynthetic epothilone B in human lung cancer cells.
Kim JC; Kim JS; Saha D; Cao Q; Shyr Y; Choy H
Radiother Oncol; 2003 Sep; 68(3):305-13. PubMed ID: 13129641
[TBL] [Abstract][Full Text] [Related]
17. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
18. C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy.
Nakata E; Hunter N; Mason K; Fan Z; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1163-73. PubMed ID: 15234052
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of radiation effects by combined docetaxel and carboplatin treatment in vitro.
Amorino GP; Hamilton VM; Choy H
Radiat Oncol Investig; 1999; 7(6):343-52. PubMed ID: 10644057
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I.
Kim JH; Kim SH; Kolozsvary A; Khil MS
Int J Radiat Oncol Biol Phys; 1992; 22(3):515-8. PubMed ID: 1310495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
